ArticleInfectious diseases and therapy2021

Randomized Prospective Open Label Study Shows No Impact on Clinical Outcome of Adding Losartan to Hospitalized COVID-19 Patients with Mild Hypoxemia.

Matthew Geriak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.